Rethinking Menopause Hormone Therapy

• by Kerri Miller

• April 23, 2026

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

• by Kathryn Wighton

• June 16, 2026

• 5 min

A self-care smartphone application for midlife women with menopausal symptoms: A proof-of-concept study

• by Takuma Ohsuga, Miho Egawa, Kaori Tsuyuki, Miki Ohtsuki, Yu Wanjie, Shi Juan, Rena Hinotani, Yoshimitsu Takahashi, Takeo Nakayama, Masaki Mandai

• June 10, 2026

Menopause may be underdocumented in EHRs

Surveys captured nearly 7 times as many menopause observations as structured clinical records, with high agreement when both sources identified menopause.

• by Andrea Surnit

• September 14, 2026

• 4 min